NASDAQ:PLSE - Pulse Biosciences Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$18.23 +0.75 (+4.29 %)
(As of 02/22/2019 04:00 PM ET)
Previous Close$17.48
Today's Range$16.95 - $18.54
52-Week Range$8.60 - $22.50
Volume101,600 shs
Average Volume82,236 shs
Market Capitalization$375.16 million
P/E RatioN/A
Dividend YieldN/A
Beta1.54
Pulse Biosciences, Inc., a clinical-stage medical technology company, develops therapeutic tissue treatment platform based on its proprietary nano-pulse stimulation (NPS) technology. Its NPS is a non-thermal, precise, and focal drug-free tissue treatment technology that initiates cell death within treated tissue used in oncology, dermatology/aesthetics, minimally invasive, and veterinary applications. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was founded in 2014 and is headquartered in Hayward, California.

Receive PLSE News and Ratings via Email

Sign-up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PLSE
CUSIPN/A
Phone510-906-4600

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$2.81 per share

Profitability

Net Income$-37,540,000.00

Miscellaneous

Employees33
Market Cap$375.16 million
Next Earnings Date5/14/2019 (Estimated)
OptionableOptionable

Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences Inc (NASDAQ:PLSE) announced its earnings results on Thursday, February, 7th. The company reported ($0.51) earnings per share for the quarter. View Pulse Biosciences' Earnings History.

When is Pulse Biosciences' next earnings date?

Pulse Biosciences is scheduled to release their next quarterly earnings announcement on Tuesday, May 14th 2019. View Earnings Estimates for Pulse Biosciences.

Has Pulse Biosciences been receiving favorable news coverage?

News stories about PLSE stock have been trending positive on Friday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Pulse Biosciences earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days.

Who are some of Pulse Biosciences' key competitors?

What other stocks do shareholders of Pulse Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Energous (WATT), Portola Pharmaceuticals (PTLA), Achaogen (AKAO), Fate Therapeutics (FATE), AbbVie (ABBV), Roku (ROKU), Advanced Micro Devices (AMD), Bausch Health Companies (BHC), Weatherford International (WFT) and Sangamo Therapeutics (SGMO).

Who are Pulse Biosciences' key executives?

Pulse Biosciences' management team includes the folowing people:
  • Mr. Darrin R. Uecker, Pres, CEO & Director (Age 52)
  • Mr. Brian B. Dow, CFO, Sr. VP of Fin. & Admin., Treasurer and Sec. (Age 49)
  • Dr. Richard Nuccitelli Ph.D., Chief Science Officer
  • Dr. Holly Hartman Ph.D., J.D., VP of Bus. Devel. & Corp. Strategy
  • Mr. David Danitz, VP of Engineering

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an initial public offering on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (2.98%), Northern Trust Corp (0.59%), Geode Capital Management LLC (0.57%), Bank of New York Mellon Corp (0.28%), Bank of America Corp DE (0.10%) and Westside Investment Management Inc. (0.09%). Company insiders that own Pulse Biosciences stock include Maky Zanganeh, Mitchell E Levinson, Robert J Greenberg, Robert W Duggan and Thierry B Thaure. View Institutional Ownership Trends for Pulse Biosciences.

Which major investors are selling Pulse Biosciences stock?

PLSE stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, BlackRock Inc., Westside Investment Management Inc. and Bank of America Corp DE. View Insider Buying and Selling for Pulse Biosciences.

Which major investors are buying Pulse Biosciences stock?

PLSE stock was purchased by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, Rhumbline Advisers and Northern Trust Corp. Company insiders that have bought Pulse Biosciences stock in the last two years include Maky Zanganeh, Mitchell E Levinson and Robert W Duggan. View Insider Buying and Selling for Pulse Biosciences.

How do I buy shares of Pulse Biosciences?

Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pulse Biosciences' stock price today?

One share of PLSE stock can currently be purchased for approximately $18.23.

How big of a company is Pulse Biosciences?

Pulse Biosciences has a market capitalization of $375.16 million. Pulse Biosciences employs 33 workers across the globe.

What is Pulse Biosciences' official website?

The official website for Pulse Biosciences is http://www.pulsebiosciences.com.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at 510-906-4600 or via email at [email protected]


MarketBeat Community Rating for Pulse Biosciences (NASDAQ PLSE)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  155 (Vote Outperform)
Underperform Votes:  157 (Vote Underperform)
Total Votes:  312
MarketBeat's community ratings are surveys of what our community members think about Pulse Biosciences and other stocks. Vote "Outperform" if you believe PLSE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PLSE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2019 by MarketBeat.com Staff

Featured Article: What is a blue-chip stock?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel